Showing results (31-40 of 168) with videos related to

Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|July 9, 2008
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole eraJesús Guinea, Sandra Recio, Teresa Peláez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|June 1, 2017
Microbiological diagnosis of biofilm-related infectionsMaría D Macià, José Luis Del Pozo, María Díez-Aguilar, et al.
Diagnostic Microbiology and Infectious Disease|October 24, 2007
Relapsing Rhodococcus equi infection in a heart transplant recipient successfully treated with long-term linezolidPatricia Muñoz, Jesús Palomo, Jesús Guinea, et al.
Antimicrobial Agents and Chemotherapy|June 23, 2010
In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogensJesús Guinea, Sandra Recio, Pilar Escribano, et al.
Mycoses|November 20, 2024
Detecting Echinocandin Resistance in C. glabrata Using Commercial Methods: Are CLSI or EUCAST Breakpoints Suitable for Categorical Classification?Pilar Escribano, Laura Alguacil Cuéllar, Almudena Álvarez-Gutiérrez, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2006
In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the EtestMarta Torres-Narbona, Jesús Guinea, José Martínez-Alarcón, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 19, 2013
[Microbiological procedures for the diagnosis, management, and study of invasive fungal infections]Emilia Canton, Julio García-Rodríguez, Estrella Martín-Mazuelos, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2011
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populationsPilar Escribano, Sandra Recio, Teresa Peláez, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing CandidemiaLaura Judith Marcos-Zambrano, Pilar Escribano, Carlos Sánchez-Carrillo, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2017
The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida sppLaura Judith Marcos-Zambrano, Marta Gómez-Perosanz, Pilar Escribano, et al.
Pageof 17